136 related articles for article (PubMed ID: 17505511)
21. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
[TBL] [Abstract][Full Text] [Related]
22. Plausible linkage of hypoxia-inducible factor (HIF) in uterine endometrial cancers.
Fujimoto J; Sato E; Alam SM; Jahan I; Toyoki H; Hong BL; Sakaguchi H; Tamaya T
Oncology; 2006; 71(1-2):95-101. PubMed ID: 17341889
[TBL] [Abstract][Full Text] [Related]
23. Expression of vascular endothelial growth factor C correlates with a poor prognosis based on analysis of prognostic factors in patients with cervical carcinomas.
Ma DM; Xu YP; Zhu L
J Obstet Gynaecol Res; 2011 Nov; 37(11):1519-24. PubMed ID: 21676077
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic study of neovascularization and VEGF expression in superficial esophageal carcinoma.
Fujii T; Sudo T; Sueyoshi S; Tanaka T; Fujita H; Shirouzu K; Ban S; Toyonaga A; Kato S; Yamana H
Int J Oncol; 2002 Dec; 21(6):1181-7. PubMed ID: 12429966
[TBL] [Abstract][Full Text] [Related]
25. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
26. Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma.
Mitsuhashi A; Suzuka K; Yamazawa K; Matsui H; Seki K; Sekiya S
Cancer; 2005 Feb; 103(4):724-30. PubMed ID: 15637689
[TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor expression in progression of cervical cancer: correlation with thymidine phosphorylase expression, angiogenesis, tumor cell proliferation, and apoptosis.
Fujiwaki R; Hata K; Iida K; Maede Y; Miyazaki K
Anticancer Res; 2000; 20(2B):1317-22. PubMed ID: 10810442
[TBL] [Abstract][Full Text] [Related]
28. Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer.
Gravdal K; Halvorsen OJ; Haukaas SA; Akslen LA
Cancer Res; 2009 Jun; 69(11):4708-15. PubMed ID: 19487287
[TBL] [Abstract][Full Text] [Related]
29. CD34 as a marker for evaluating angiogenesis in cervical cancer.
Vieira SC; Silva BB; Pinto GA; Vassallo J; Moraes NG; Santana JO; Santos LG; Carvasan GA; Zeferino LC
Pathol Res Pract; 2005; 201(4):313-8. PubMed ID: 15991838
[TBL] [Abstract][Full Text] [Related]
30. Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in ovarian cancer.
Fujimoto J; Toyoki H; Sakaguchi H; Jahan I; Alam SM; Tamaya T
Oncol Rep; 2006 Jan; 15(1):21-5. PubMed ID: 16328030
[TBL] [Abstract][Full Text] [Related]
31. Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement.
Hawighorst H; Knapstein PG; Weikel W; Knopp MV; Zuna I; Knof A; Brix G; Schaeffer U; Wilkens C; Schoenberg SO; Essig M; Vaupel P; van Kaick G
Cancer Res; 1997 Nov; 57(21):4777-86. PubMed ID: 9354439
[TBL] [Abstract][Full Text] [Related]
32. Angiogenesis in malignancies of the female genital tract.
Abulafia O; Triest WE; Sherer DM
Gynecol Oncol; 1999 Feb; 72(2):220-31. PubMed ID: 10021305
[TBL] [Abstract][Full Text] [Related]
33. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.
Shang ZJ; Li JR
J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226
[TBL] [Abstract][Full Text] [Related]
34. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
[TBL] [Abstract][Full Text] [Related]
35. Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine cervical cancers.
Fujimoto J; Sakaguchi H; Hirose R; Ichigo S; Tamaya T
Br J Cancer; 1999 Mar; 79(7-8):1249-54. PubMed ID: 10098767
[TBL] [Abstract][Full Text] [Related]
36. LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix.
Hedman H; Lindström AK; Tot T; Stendahl U; Henriksson R; Hellberg D
Acta Oncol; 2010 Aug; 49(6):812-5. PubMed ID: 20553099
[TBL] [Abstract][Full Text] [Related]
37. PlGF expression in pre-invasive and invasive lesions of uterine cervix is associated with angiogenesis and lymphangiogenesis.
Yang S; Cheng H; Cai J; Cai L; Zhang J; Wang Z
APMIS; 2009 Nov; 117(11):831-8. PubMed ID: 19845534
[TBL] [Abstract][Full Text] [Related]
38. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical evaluation of tumour angiogenesis in adenocarcinoma and squamous cell carcinoma of lung.
Sikora J; Słodkowska J; Radomyski A; Giedronowicz D; Kobos J; Kupis W; Rudzinski P
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():271-9. PubMed ID: 9337544
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
